ALYREF and cervical carcinoma: Thus, our findings illustrate a regulatory mechanism of RNA m5C-mediated radioresistance and provide a therapeutic rationale for targeting the NSUN6/ALYREF-m5C-NDRG1 signaling axis in cervical cancer.